TLSI   $3.91  -4.17% Market Open

TriSalus Life Sciences, Inc.
Total Cash 16.48M
totalCashPerShare 0.562
EBITDA -51.70M
Total Debt 22.76M
quickRatio 1.766
currentRatio 2.329
Total Revenue 24.74M
debtToEquity
Revenue/Share 1.178
ROA -1.3315401
ROE
grossProfits
freeCashflow -52.96M
operatingCashflow -54.59M
earningsGrowth
revenueGrowth 0.597
grossMargins 0.87654
ebitdaMargins -2.09023
operatingMargins -1.10999
profitMargins -2.19708
enterpriseValue 123.82M
forwardPE -3.3983054
floatShares 20.63M
sharesOutstanding 30.49M
sharesShort 62.12K
sharesShortPriorMonth 31.48K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.43%
heldPercentInstitutions 0.16%
Short Ratio help_outline 1.42%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue -0.889
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -57.21M
trailingEps 52.25%
forwardEps -1.18%
enterpriseToEbitda -2.40
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.35 3Q 2024
institutionsCount 28
lastUpdated Nov. 2, 2024, 6:35 a.m.